18 April 2007

Low vit. D levels = cancer risk

Vitamin D deficiency is linked to an increased risk of cancer, researchers have told attendees at the annual meeting of the American Association for Cancer Research.

Vitamin D deficiency is linked to an increased risk of cancer, researchers have told attendees at the annual meeting of the American Association for Cancer Research, with results from a clinical trial hoped to show benefits of high-dose vitamin D replacement in individuals with a high risk of lung cancer.

The link between vitamin D intake and protection from cancer dates from the 1940s when Frank Apperly demonstrated a link between latitude and deaths from cancer, and suggested that sunlight gave "a relative cancer immunity."

Two inactive precursors
Vitamin D refers to two biologically inactive precursors - D3, also known as cholecalciferol, and D2, also known as ergocalciferol. The former, produced in the skin on exposure to UVB radiation (290 to 320nm), is said to be more bioactive. The latter is derived from plants and only enters the body via the diet.

Both D3 and D2 precursors are hydroxylated in the liver and kidneys to form 25- hydroxyvitamin D (25(OH)D), the non-active 'storage' form, and 1,25-dihydroxyvitamin D (1,25(OH)2D), the biologically active form that is tightly controlled by the body.

Increased risk of number of cancers
Donald Trump, president and CEO of Roswell Park Cancer Institute told attendees at the American Association for Cancer Research's centennial meeting that substantial epidemiological data indicate a link between low vitamin D levels and an increased risk of a number of cancers.

Trump said that no large-scale prospective trials have been conducted to test the hypothesis that aggressive vitamin D supplementation may influence cancer risk, and Roswell Park Cancer Institute recently initiated a clinical trial of high-dose vitamin D3 in individuals with high risk of lung cancer.

"The goal of this study is to delineate the biologic effects of 1,25(OH)2D supplementation in high-risk patients," said Trump.

Preclinical studies have demonstrated an anti-proliferative and pro-differentiative effects of high-dose 1,25(OH)2D in vitro and in vivo, said Trump, with all tumour models sensitive to vitamin D.

"While preclinical data and limited clinical data strongly suggest that 1,25(OH)2D… has a role in the suppression of established cancer, there are numerous unanswered questions about optimal dose, schedule and formulation of 1,25(OH)2D," said Trump.

More vitamin D necessary
Calls to increase vitamin D intake have been growing. Indeed, only recently fifteen experts from universities, research institutes, and university hospitals around the world called for international agencies to "reassess as a matter of high priority" dietary recommendations for vitamin D because current advice is outdated and puts the public at risk of deficiency (The American Journal of Clinical Nutrition, Vol. 85, pp. 860-868).

A recent review of the science reported that the tolerable upper intake level for oral vitamin D3 should be increased five-fold, from the current tolerable upper intake level (UL) in Europe and the US of 2000 International Units (IU), equivalent to 50 micrograms per day, to 10 000 IU (250 micrograms per day). - (Decision News Media, April 2007)

Read more:
Fruit and veg vs. cancer
Vitamin D halves cancer risk


Read Health24’s Comments Policy

Comment on this story
Comments have been closed for this article.

Live healthier

Contraceptives and you »

Scientists create new contraceptive from seaweed Poor long-term birth control training leads to 'accidents'

7 birth control myths you should stop believing

Will the Pill make you gain weight? Can you fall pregnant while breastfeeding? We bust seven common myths about birth control.

Your digestive health »

Causes of digestive disorders 9 habits that could hurt your digestive system

Your tummy rumblings might help diagnose bowel disorder

With the assistance of an 'acoustic belt', doctors can now determine the cause of your tummy troubles.